Percutaneous Coronary Intervention
269
44
54
99
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
18 trials with published results (7%)
Research Maturity
99 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.5%
12 terminated out of 269 trials
89.2%
+2.6% vs benchmark
22%
60 trials in Phase 3/4
18%
18 of 99 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 99 completed trials
Clinical Trials (269)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
A Nurse-Led Program to Improve Patient Health Promotion Behaviors Among Elderly Patients After PCI
Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI
Comparative Effectiveness of Dual Antihypertensive Regimens in Patients After Percutaneous Coronary Intervention
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Comparison of Safety and Efficacy Between the Robot-assisted System AVIAR (MX-02) Procedure and Conventional Manual Procedure in Patients Requiring Percutaneous Coronary Intervention
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)
The EPIVER Randomized Controlled Trial
Adjunctive, Low-dose tPA in Primary PCI for STEMI
Effect of Virtual Reality During Femoral Sheath Removal
Polymer-free Sirolimus Eluting Stent: Real-world Investigation of Safety and Outcomes
Effects of Diaphragmatic and Abdominal Neuromuscular Electrical Stimulation in Post-PCI Patients
Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization
Baduanjin Intervention in Clinical Studies After Coronary Revascularization Surgery
Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)
Cardiac Rehab Referral Nudges
Computed Tomography Angiography Based Procedural Planning in PeRcutaneOus Coronary InterVEntion
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions